VBI Vaccines Inc. (VBIV)
NASDAQ: VBIV
· Real-Time Price · USD
0.07
-0.06 (-47.33%)
At close: Aug 07, 2024, 8:00 PM
VBI Vaccines Revenue
VBI Vaccines reported an annual revenue of $8.68M, reflecting a 702.4% growth. For the quarter ending March 31, 2024, VBI Vaccines generated $1.21M in revenue.
Revenue (ttm)
$8.68M
Revenue Growth
702.4%
Price / Sales Ratio
1.05
Revenue / Employee
$66.27K
Employees
131
Market Cap
1.87M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|